Long Beach Memorial Medical Center
Long Beach, California, 90806, United States
NCT Number: NCT05593211
The primary objective for this study is to assess safety and performance of the Kronos Electrocautery Device for electrocautery procedures following coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Long Beach, California, 90806, United States
The Kronos Electrocautery Device is intended to be used in electrocautery procedures to control bleeding by use of electrical current to heat the device probe tip that is applied directly to the target tissue area of treatment. Prospective, multi-center, single-arm study with consecutive, eligible subject enrollment at each site. Patients who require a coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc., will be eligible to participate in this study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Kronos Electrocautery Device is a disposable electrocautery device that can cauterize deep tissue through a standard biopsy procedure guide needle. This device is intended to coagulate the tissue surrounding the core biopsy channel during withdrawal to reduce or eliminate significant post-procedural bleeding. Currently, the Kronos Electrocautery Device consists of one (1) size. As such, the existing Kronos Electrocautery Device is chosen as the worst-case condition
Time frame: 14 days
Patients will be contacted on day 14 post-procedure and asked a series of questions regarding Adverse Events related to the procedure.
Time frame: 1 hour post procedure
The weight of 10 gauze pads is taken prior to the procedure. Post-procedure, those same 10 gauze pads used at biopsy access site are weighed again to measure in grams, the amount of blood loss. The scale ranges from 1 (unacceptable) to 5 (excellent).
Time frame: 8 hours post procedure
Measuring the amount of patient who did not need an ultrasound examination due to observation of bleeding
Time frame: 14 days
Patients will be contacted on day 14 post-procedure and asked a series of questions regarding Adverse Events related to the procedure. Measuing the amount of patients who did not require secondary reintervention.
Time frame: 8 hours post procedure
Single Pass Inc
Industry
Feasibility Study of the Kronos Electrocautery Device
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03767517
Brain Diseases, Cancer
Alexander City, Alabama, United States
View Trial DetailsNCT05616442
Digestive System Diseases, Fatty Liver
Tanta, Egypt
View Trial DetailsNCT03297073
Digestive System Diseases, Hepatic Disease
Lille, France
View Trial DetailsNCT05822635
Bile Duct Diseases, Biliary Tract Diseases
Indianapolis, Indiana, United States
View Trial Details